Patents Assigned to Pharmachem Laboratories, Inc.
-
Publication number: 20130164275Abstract: The present invention provides a method for treating acidosis in a ruminant. The method includes administering an effective amount of a naturally derived inhibitor of a carbohydrate degrading enzyme to the ruminant. Such enzymes include amylase and glucosidase. In addition, the carbohydrate degrading enzyme may be endogenous or exogenous to the ruminant.Type: ApplicationFiled: October 26, 2010Publication date: June 27, 2013Applicant: PHARMACHEM LABORATORIES, INC.Inventors: Andrea Lacorte, Alessandro Lotto
-
Patent number: 8338564Abstract: A method of preparing phytosterols from tall oil pitch containing steryl esters comprises the steps of converting the steryl esters to free phytosterols while in the pitch to produce a modified pitch containing the free phytosterols; removing light ends from the modified pitch by evaporation to produce a bottom fraction containing the free phytosterols; evaporating the bottom fraction to produce a light phase distillate containing the free phytosterols; dissolving the light phase distillate in a solvent comprising an alcohol to produce a solution containing the free phytosterols; cooling the solution to produce a slurry with the free phytosterols crystallized in the slurry; and, washing and filtering the slurry to isolate the crystallized phytosterols.Type: GrantFiled: August 4, 2010Date of Patent: December 25, 2012Assignee: Pharmachem Laboratories, Inc.Inventors: Alfred Wong, Hugh Sven Oscar Norman, Angus Kirke MacMillan
-
Patent number: 8309156Abstract: A composition for use in foods, beverages and nutraceuticals that includes one or more non-sterol emulsifiers, each having an HLB value of greater than 14 and one or more sterols or stanols or mixtures thereof.Type: GrantFiled: December 20, 2006Date of Patent: November 13, 2012Assignee: Pharmachem Laboratories, Inc.Inventor: Jerzy Zawistowski
-
Publication number: 20120093975Abstract: The invention is directed to a composition comprising chromium and L-Arabinose. The invention is also directed to a method for decreasing the metabolization of sucrose in a host in need thereof by administering a composition comprising chromium and L-Arabinose to a host and a method for inhibiting the glycemic response to a meal containing sucrose in a host in need thereof by administering a composition comprising chromium and L-Arabinose to a host.Type: ApplicationFiled: May 14, 2010Publication date: April 19, 2012Applicant: PHARMACHEM LABORATORIES, INC.Inventor: Mitch Skop
-
Patent number: 7138113Abstract: A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the active ingredient. The composition of the invention provides a method for increasing the stability and bioactivity of the active ingredient. A method is also provided for administering an active ingredient to a host by utilizing a composition of the invention.Type: GrantFiled: October 12, 2004Date of Patent: November 21, 2006Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Publication number: 20060147565Abstract: The present invention provides a purified amylase inhibitor obtained by a superior process that includes extracting ground beans with supercritical carbon dioxide. The invention also provides a method for inducing weight loss in a mammal in need thereof comprising administering to the mammal, an effective amount of an amylase inhibitor obtained by the superior process. A method for improving post-prandial glucose tolerance in a diabetic mammal comprising administering to the mammal, an effective amount of an amylase inhibitor obtained by the superior process, is also provided.Type: ApplicationFiled: June 27, 2003Publication date: July 6, 2006Applicant: PHARMACHEM LABORATORIES, INC.Inventors: Mitchell Skop, Dilip Chokshi
-
Patent number: 7049288Abstract: The present invention is for compositions containing phaseolamin and a mineral, such as chromium or vanadium or both, where the mineral is bound by a glycoprotein matrix. The present invention is also directed to methods for controlling carbohydrate cravings, inducing weight loss, reducing insulin requirements in a diabetic, and inhibiting the absorption of dietary starch by administering a composition of the invention.Type: GrantFiled: November 24, 2004Date of Patent: May 23, 2006Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Patent number: 6942856Abstract: A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the active ingredient. The composition of the invention provides a method for increasing the stability and bioactivity of the active ingredient. A method is also provided for administering an active ingredient to a host by utilizing a composition of the invention.Type: GrantFiled: April 19, 2002Date of Patent: September 13, 2005Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Patent number: 6900174Abstract: The present invention is for compositions containing phaseolamin and a mineral, such as chromium or vanadium or both, where the mineral is bound by a glycoprotein matrix. The present invention is also directed to methods for controlling carbohydrate cravings, inducing weight loss, reducing insulin requirements in a diabetic, and inhibiting the absorption of dietary starch by administering a composition of the invention.Type: GrantFiled: September 3, 2002Date of Patent: May 31, 2005Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Patent number: 6867024Abstract: A composition is provided that includes an ubiquinone, such as CoQ10, bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the ubiquinone. The composition of the invention provides a method for increasing the stability and bioactivity of the ubiquinone. A method is also provided for administering an ubiquinone to a host by utilizing a composition of the invention.Type: GrantFiled: April 19, 2002Date of Patent: March 15, 2005Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Patent number: 6864231Abstract: A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the active ingredient. The composition of the invention provides a method for increasing the stability and bioactivity of the active ingredient. A method is also provided for administering an active ingredient to a host by utilizing a composition of the invention.Type: GrantFiled: July 16, 2001Date of Patent: March 8, 2005Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Publication number: 20040228931Abstract: The present invention provides a composition and methods of using composition consisting essentially of a soy component, chasteberry, clover, and black cohosh, in a suitable carrier, optionally with each of the soy component, chasteberry, clover, and black cohosh is enrobed in a glycoprotein matrix.Type: ApplicationFiled: May 12, 2003Publication date: November 18, 2004Applicant: Pharmachem Laboratories, Inc.Inventors: Dilip Chokshi, Mitch Skop
-
Patent number: 6806069Abstract: A composition is provided that includes an ubiquinone, such as CoQ10, bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the ubiquinone. The composition of the invention provides a method for increasing the stability and bioactivity of the ubiquinone. A method is also provided for administering an ubiquinone to a host by utilizing a composition of the invention.Type: GrantFiled: January 9, 2001Date of Patent: October 19, 2004Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Patent number: 6797287Abstract: The present invention is for compositions containing phaseolamin and a mineral, such as chromium or vanadium or both, where the mineral is bound by a glycoprotein matrix. The present invention is also directed to methods for controlling carbohydrate cravings, inducing weight loss, reducing insulin requirements in a diabetic, and inhibiting the absorption of dietary starch by administering a composition of the invention.Type: GrantFiled: September 25, 2001Date of Patent: September 28, 2004Assignee: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Publication number: 20030059403Abstract: The present invention is for compositions containing phaseolamin and a mineral, such as chromium or vanadium or both, where the mineral is bound by a glycoprotein matrix. The present invention is also directed to methods for controlling carbohydrate cravings, inducing weight loss, reducing insulin requirements in a diabetic, and inhibiting the absorption of dietary starch by administering a composition of the invention.Type: ApplicationFiled: September 3, 2002Publication date: March 27, 2003Applicant: Pharmachem Laboratories, Inc.Inventor: Dilip Chokshi
-
Publication number: 20030003081Abstract: A composition is provided that includes an ubiquinone, such as CoQ10, bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the ubiquinone. The composition of the invention provides a method for increasing the stability and bioactivity of the ubiquinone. A method is also provided for administering an ubiquinone to a host by utilizing a composition of the invention.Type: ApplicationFiled: April 19, 2002Publication date: January 2, 2003Applicant: PharmaChem Laboratories, Inc.Inventor: Dilip Chokshi
-
Publication number: 20020182183Abstract: A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the active ingredient. The composition of the invention provides a method for increasing the stability and bioactivity of the active ingredient. A method is also provided for administering an active ingredient to a host by utilizing a composition of the invention.Type: ApplicationFiled: April 19, 2002Publication date: December 5, 2002Applicant: PharmaChem Laboratories, Inc.Inventor: Dilip Chokshi
-
Patent number: 4867986Abstract: Storage-stable, bio-available, free-flowing, microemulsified, Omega-three acid-containing oil compositions in the form of microspheres and macrospheres, said compositions consisting essentially of (1) up to about 70% by weight of Omega-three acid-containing oil, and (2) gelatin, in which the oil is microemulsified by the gelatin; processes for their preparation; and product applications (including tablet-type solid forms, dry powders, and spoonable, drinkable emulsions).Type: GrantFiled: July 17, 1987Date of Patent: September 19, 1989Assignee: Pharmachem Laboratories, Inc.Inventors: Mahesh Desai, Frank Molinaro